Product Information
TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Padagis US LLC, priced at $5.1316 per ML under NDC 00574403125. Its NADAC has been published 213 times since Jun 1, 2022.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Padagis US LLCNDC
00574403125
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA212715On Market Since
3/17/2022
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1316 per ML |
|---|---|
| All-time high | $14.8922 (Jul 13, 2022) |
| All-time low | $4.4089 (Dec 17, 2025) |
| 52-week high | $6.6531 |
| 52-week low | $4.4089 |
| Median price | $6.5259 |
| Average price | $7.2729 |
| Largest weekly change | -44.9% (Jul 17, 2024) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Padagis US LLC, is $5.1316 per ML (NDC 00574403125), effective Jun 24, 2026.
How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 63.6%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Since Jun 1, 2022, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $4.4089 (Dec 17, 2025) to a high of $14.8922 (Jul 13, 2022), with a median of $6.5259 per ML.
Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, TOBRAMYCIN-DEXAMETH OPHTH SUSP, is $4.2803 per ML — about 17% below TOBRAMYCIN-DEXAMETH OPHTH SUSP.
Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?
TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 00574403125) is labeled by Padagis US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification